Archives
-
Interpretable Radiopathomics in Gastric Cancer
2026-09-04
This multicenter study developed a radiopathomics signature that combines baseline computed tomography with digital H&E pathology images to predict response to immunotherapy-based combination therapy in gastric cancer. Its strong validation performance, survival stratification, and association with immune features support multimodal, interpretable biomarkers while highlighting the need for prospective and technically standardized validation.
-
Entecavir (BMS200475) HBV Research Workflows
2026-09-03
Build more informative HBV assays with Entecavir by combining dose-response testing, resistant-strain comparisons, viral DNA quantification, and cytotoxicity controls. This workflow also separates chronic hepatitis B virus replication inhibition from the weaker evidence base for treating acute infection.
-
HRD1–SEL1L, p97, and Stress Granule Homeostasis
2026-09-03
The 2024 iScience study identifies the HRD1–SEL1L ubiquitin ligase as a regulator of heat shock-induced stress granule homeostasis and connects this activity to the BiP–PERK–eIF2α branch of endoplasmic reticulum stress. Its findings clarify how ubiquitin-dependent protein quality control and stress signaling cooperate, while providing a mechanistic framework for studying p97-linked proteostasis disorders.
-
Berberrubine Chloride: From Mechanism to Translation
2026-09-02
Berberrubine chloride is emerging as a mechanistically versatile research tool spanning IMPDH2, thioredoxin reductase, inflammatory signaling, urate transport, and tumor biology. This thought-leadership perspective shows how translational researchers can move beyond single-pathway screening toward target-engagement, model-selection, and exposure-aware workflows.
-
PDX1 Mutations, Pancreatic Agenesis, and m6A
2026-09-02
Zhang et al. developed PDX1-mutant cynomolgus macaques to examine pancreatic agenesis and MODY4-related mechanisms in a primate model. The study connects PDX1 haploinsufficiency with altered m6A methylation and shows that METTL3 overexpression can restore function in heterozygous PDX1-mutant islet organoids.
-
NHE1, Olfr2, and Octanal in Atherosclerosis
2026-09-01
This Scientific Reports study identifies NHE1 as a downstream effector linking octanal–Olfr2 signaling to calcium-dependent oxidative and inflammatory responses in macrophages. Using ApoE−/− mice and RAW264.7 cells, the authors show that NHE1 inhibition or loss of function reduces plaque-associated inflammation, foam cell formation, and related signaling, while also defining experimental strategies for testing this pathway.
-
Praeruptorin A Targets ERK/MMP1 in HCC Metastasis
2026-09-01
The reference study shows that praeruptorin A suppresses migration and invasion of human hepatocellular carcinoma cells without broadly impairing viability or cell-cycle distribution. Its key mechanistic contribution is the use of ERK knockdown to connect ERK signaling with MMP1 repression and the resulting antimetastatic phenotype.
-
TBST (Tris-Buffered Saline and Tween 20) Guide
2026-08-31
TBST (Tris-Buffered Saline and Tween 20), SKU K1199, is a ready-to-use buffered detergent solution for reducing nonspecific binding and background during antibody-based workflows. It is suited to Western blotting, immunofluorescence, immunohistochemistry, and immunocytochemistry, but should be validated or avoided when non-ionic detergents interfere with assay chemistry or detection.
-
Bifendate Inhibits Autophagy at Multiple Steps
2026-08-31
The reference study shows that Bifendate (DDB) affects several late autophagy and lysosomal processes rather than producing a single undifferentiated change in autophagy markers. In oleic acid-treated cells, this activity was associated with reduced lipid-droplet accumulation, providing a mechanistic basis for further study of DDB in liver disease and lipid-metabolism models.
-
GSK3 Inhibition as Host-Directed TB Therapy
2026-08-30
The 2024 iScience study identifies glycogen synthase kinase 3 as a host pathway that supports intracellular Mycobacterium tuberculosis growth. By combining pharmacological screening with CRISPR, RNA interference, apoptosis analysis, and phospho-proteomics, the authors provide a mechanistically supported framework for host-directed tuberculosis therapy.
-
Adipose-Neural Signaling in Cardiac Arrhythmia
2026-08-29
Fan et al. developed a stem cell-based coculture model showing that epicardial adipose tissue can influence cardiomyocyte electrical instability through a leptin–sympathetic neuron–NPY/Y1R pathway. The study connects adipocyte-derived leptin with neuronal NPY release, NCX and CaMKII activation, and arrhythmic phenotypes, while patient observations support clinical relevance in atrial fibrillation.
-
Ethacridine lactate monohydrate for assay control
2026-08-28
Ethacridine lactate monohydrate provides a flexible, research-grade approach to microbial control in biochemical and cellular workflows. This guide shows how to prepare it, separate antiseptic effects from differentiation biology, and troubleshoot solvent, toxicity, and reproducibility problems.
-
Ziprasidone Targets GOT1 in Pancreatic Cancer
2026-08-28
A 2022 Journal of Molecular Medicine study identifies ziprasidone as a non-competitive inhibitor of GOT1, a metabolic enzyme that supports glutamine utilization and redox maintenance in pancreatic ductal adenocarcinoma. By combining enzyme assays, target-engagement analyses, metabolomics, cell-based experiments, and xenografts, the researchers link GOT1 inhibition to impaired proliferation, migration, and tumor growth.
-
BMAL1, STAT6, and Endothelial Apoptosis in CNV
2026-08-27
The reference study identifies BMAL1 as an antiapoptotic regulator in endothelial cells and connects this activity to transcriptional repression of STAT6 in alkali-burn corneal neovascularization. Its combination of endothelial genetic modification, proteomics, rescue experiments, and promoter reporting provides a mechanistic framework for interpreting how BMAL1 may influence vascular injury responses.
-
Berberine, RXRα/PPARγ, and SASP in Atherosclerosis
2026-08-27
The 2025 reference study identifies an RXRα/PPARγ/NEDD4 axis through which berberine suppresses senescence-associated secretory phenotype inflammation in macrophage-derived foam cells and atherosclerotic plaques. Its combination of mouse studies, foam-cell assays, Smart-seq analysis, and macrophage-specific RXRα knockdown connects nuclear-receptor activity with ubiquitin-dependent regulation of the GATA4/p62 complex.